Login

Kuvera interviews Rahul Singh, Chief Investment Officer - Equities at Tata Asset Management, about Multi Cap Funds.|Gaurav Rastogi is the CEO of Kuvera 00:10:00

Share On Facebook Share On Twitter

Gaurav Rastogi is the CEO of Kuvera

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
3tentos CEO Luiz Osório Dumoncel on R$2 Billion Investment in Agribusiness and 2024 Growth | Luiz Osório Dumoncel, CEO, Três Tentos Agroindustrial SA.
00:10:00
"John Richards, of Brickability Group PLC (AIM: BRCK), celebrates their inaugural acquisition in the renewable energy products sector, valued at £5.5 million."|John Richards is currently the Non-Executive Chairman at Brickability Group Plc
00:10:00
High-Speed Data in Non-Terrestrial Applications | Richard Gibbs , Chief Executive Officer of Filtronic Plc
00:10:00
Disrupting the Disruptors: How VCs Are Adapting to a Changing Landscape|Santi Subotovsky,Emergence, Capital Partners
00:10:00
Beijer Ref India Pvt. Ltd., a subsidiary of Beijer Ref AB, Sweden, begins its journey under the name Patton Refrigeration India Pvt Ltd.||Kate Swann is Chairperson of Beijer Ref
00:10:00
Great Southern Copper Unveils Major Copper-Gold System at San Lorenzo | Sam Garrett , CEO, Great Southern Copper PLC.
00:00:00
RedHill Biopharma (NASDAQ: RDHL) Presenting the company - Gay Goldberg, CBO, Redhill Biopharma Ltd
00:10:00
The Future of 3D Printing: Insights from a Physicist and Entrepreneur
00:10:00
Over $6B assets under management, 31 IPOs, and 80+ acquisitions|Rodolfo Gonzalez,General Partner,Foundation Capital
00:10:00
Allspring’s vision is to inspire a new era of investing that pursues both financial returns and positive outcomes. Diverse perspectives power our investment strategies through a unified platform and a commitment to our clients.| Joe Sullivan,Chief Executi
00:10:00
Navigating Financial Complexity: The Vital Role of Human Advisors | Dave Butler, CEO , Dimensional Fund Advisors.
00:10:00
Pioneering Virology Company Aims to Develop Functional Cure for Hepatitis B and Treatments for Coronavirus Infections | William H. Collier, CEO, Arbutus Biopharma Corp.

© 2017 - Neuhu+